Qyuns Therapeutics Co., Ltd. is a clinical biopharmaceutical company focusing on biotherapeutics for autoimmune and allergic diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 337 full-time employees. The company went IPO on 2024-03-20. The firm is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The firm's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The firm is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The firm's core products include QX002N and QX005N.
02509.HK stock price ended at $19.8 on Jueves, after dropping 1.98%
On the latest trading day Feb 12, 2026, the stock price of 02509.HK fell by 1.98%, dropping from $20.22 to $19.80. During the session, the stock saw a volatility of 3.69%, with prices oscillating between a daily low of $19.50 and a high of $20.22. On the latest trading day, the trading volume for 02509.HK decreased by 205.8K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 119.4K shares were traded, with a market value of approximately $4.4B.
Señales Técnicas de 02509.HK
Resumen de Señales Técnicas
Señales de compra 1
Señales Neutras 2
Señales de venta 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02509.HK actualmente presenta 1 señales de compra y 4 señales de venta. La acción ha estado en una tendencia bajista desde 12:00 AM, con un cambio total en el precio de -6.07% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Sell para el mediano plazo.
Señales alcistas/bajistas para 02509.HK
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para 02509.HK. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.